1598 Mrv0541 02231215352 d 999年22日23日0 0 1 0 V2000型5.9559 -0.2382 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 2.6625 1.5588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4474 -1.2387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7079 -1.8618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.3488 -2.3033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.8613 -0.6507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6059 1.1908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.8434 1.9053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.8613 0.1743 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.0295 0.1778 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.6459 0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0295 -0.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4474 0.7623 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 4.6459 -0.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1309 -0.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.5504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9009 -1.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3684 0.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.1934 0.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4309 1.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7595 0.8264 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.4195 -0.0742 0.0000 H 0 0 0 0 0 0 0 0 0 0 15 0 0 1 1 0 0 0 0 1 18 13 1 0 0 0 0 2 1 1 0 0 0 3 12 2 0 0 0 0 4 17 1 0 0 0 0 5 17 2 0 0 0 0 6 9 1 0 0 0 0 6 12 1 0 0 0 0 6 14 1 0 0 0 0 7 19 1 0 0 0 0 7 20 2 0 0 0 0 8 20 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 9 21 1 6 0 0 0 10 12 1 0 0 0 0 10 13 1 0 0 0 0 10 22 1 1 0 0 0 11 15 1 0 0 0 0 13 16 1 0 0 0 0 14 15 2 0 0 0 0 14 17 1 0 0 0 0 18 19 1 0 0 0 0 M >结束
DB01598 >
drugbank >
[H] [C@] 12 cc (SCC \ N = C \ N) = C (N1C (= O) [C@] 2 [C@@H] ([H]) (C) O) C (O) = O >
InChI = 1 s / C12H17N3O4S c1-6 (16) 9-7-4-8 (20-3-2-14-5-13) 10 (12 (18) 19) 15 (7) 11 (9) 17 / h5-7, 9日16 H, 2-4H2, 1 h3 (H2, 13、14) (19) H, 18日/ t6 -, 7 - 9 - m1 / s1 >
ZSKVGTPCRGIANV-ZXFLCMHBSA-N >
C12H17N3O4S >
299.346 >
299.093976737 >
6 >
37 >
0.0005644146216183752 >
31.096207372789912 >
1 >
3 >
0 >
0 >
3 - ((5 r, 6 s) {2 - [(E) - (aminomethylidene)氨基)乙基}sulfanyl) 6 - [(1 r) 1-hydroxyethyl] 7-oxo-1-azabicyclo [3.2.0] hept-2-ene-2-carboxylic酸>
-0.19 >
-3.851167554456184 >
-2.59 >
0 >
0 >
2 >
0 >
15.000723709271549 >
3.4412917848266447 >
10.87815287695515 >
116.21999999999998 >
75.84340000000002 >
6 >
1 >
7.76 e-01 g / l >
生物素>
0 >
DB01598 >
批准>
Imipenem >
(5 R, 6 s) 3 - ((2 - (Formimidoylamino)乙基)含硫的)6 - ((R) 1-hydroxyethyl) 7-oxo-1-azabicyclo (3.2.0) hept-2-ene-2-carboxylic酸;(5 R, 6 s) 3 - (2-Formimidoylamino-ethylsulfanyl) 6 - ((R) 1-hydroxy-ethyl) 7-oxo-1-aza-bicyclo [3.2.0] hept-2-ene-2-carboxylic酸;(5 R, 6 s) 6 - ((R) 1-hydroxyethyl) 3 - (2 - (iminomethylamino) ethylthio) 7-oxo-1-azabicyclo (3.2.0) hept-2-ene-2-carbonsaeure;Imipenem;Imipenem无水;Imipenemum;N-formimidoyl thienamycin;N-formimidoylthienamycin >
Imipenem;Imipenem Cilastatin;Imipenem和Cilastatin注射;Imipenem和Cilastatin注射USP;Imipenem和Cilastatin注入,USP;Primaxin;Primaxin 250;Primaxin 500;Primaxin第四;第四Primaxin 250/250 Add-vantage瓶; Primaxin IV 500; Primaxin Im; Recarbrio; Taro-imipenem-cilastatin >
Imipenem一水$ $ $ $